Toronto Dominion Bank Zynerba Pharmaceuticals, Inc. Transaction History

Toronto Dominion Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$0.87 - $1.36 $568 - $888	653 Added 162.03%	1,056 $1,000
Q1 2022 May 09, 2022	SELL	$1.83 - $3.02 $1,026 - $1,694	-561 Reduced 58.2%	403 $1,000
Q4 2021 Feb 04, 2022	BUY	$2.88 - $4.3 $1,912 - $2,855	664 Added 221.33%	964 $3,000
Q3 2021 Nov 08, 2021	BUY	$3.72 - $5.35 $1,116 - $1,605	300 New	300 $1,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

Stay updated on Toronto Dominion Bank with notifications on news.